Literature DB >> 21161301

Migraine is a neuronal disease.

J Tajti1, A Párdutz, E Vámos, B Tuka, A Kuris, Zs Bohár, A Fejes, J Toldi, L Vécsei.   

Abstract

Migraine is a common, paroxysmal, highly disabling primary headache disorder with a genetic background. The primary cause and the origin of migraine attacks are enigmatic. Numerous clinical and experimental results suggest that activation of the trigeminal system (TS) is crucial in its pathogenesis, but the primary cause of this activation is not fully understood. Since activation of the peripheral and central arms of the TS might be related to cortical spreading depression and to the activity of distinct brainstem nuclei (e.g. the periaqueductal grey), we conclude that migraine can be explained as an altered function of the neuronal elements of the TS, the brainstem, and the cortex, the centre of this process comprising activation of the TS. In light of our findings and the literature data, therefore, we can assume that migraine is mainly a neuronal disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21161301     DOI: 10.1007/s00702-010-0515-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  202 in total

Review 1.  Acute migraine therapy: the newer drugs.

Authors:  J Schoenen
Journal:  Curr Opin Neurol       Date:  1997-06       Impact factor: 5.710

Review 2.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

3.  A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology.

Authors:  Louise Dickson; Ichiro Aramori; James McCulloch; John Sharkey; Keith Finlayson
Journal:  Neuropharmacology       Date:  2006-08-23       Impact factor: 5.250

4.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

5.  5-HT-Immunoreactive fibers in the trigeminal nuclear complex of the rat.

Authors:  E C Cropper; J S Eisenman; E C Azmitia
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

6.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 7.  Recent advancements in anti-migraine drug research: focus on attempts to decrease neuronal hyperexcitability.

Authors:  Hedvig Bölcskei; Bence Farkas; Pál Kocsis; István Tarnawa
Journal:  Recent Pat CNS Drug Discov       Date:  2009-01

8.  The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis.

Authors:  D D Mitsikostas; M Sanchez del Rio; C Waeber; M A Moskowitz; F M Cutrer
Journal:  Pain       Date:  1998-05       Impact factor: 6.961

9.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 10.  Clinical pharmacokinetics of probenecid.

Authors:  R F Cunningham; Z H Israili; P G Dayton
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

View more
  15 in total

1.  Diverse effects of Brilliant Blue G administration in models of trigeminal activation in the rat.

Authors:  Zsuzsanna Bohár; Gábor Nagy-Grócz; Annamária Fejes-Szabó; Lilla Tar; Anna M László; Alexandra Büki; Nikolett Szabadi; Veronika Vraukó; László Vécsei; Árpád Párdutz
Journal:  J Neural Transm (Vienna)       Date:  2015-08-23       Impact factor: 3.575

Review 2.  Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update.

Authors:  János Tajti; Délia Szok; Anett Csáti; László Vécsei
Journal:  Curr Pain Headache Rep       Date:  2016-01

3.  A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H₃ receptor stably expressed in CHO-K1 cells.

Authors:  Cecilia Flores-Clemente; Angélica Osorio-Espinoza; Juan Escamilla-Sánchez; Rob Leurs; Juan-Manuel Arias; José-Antonio Arias-Montaño
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

4.  Inhibitory effect of high-frequency greater occipital nerve electrical stimulation on trigeminovascular nociceptive processing in rats.

Authors:  Olga A Lyubashina; Sergey S Panteleev; Alexey Y Sokolov
Journal:  J Neural Transm (Vienna)       Date:  2016-09-27       Impact factor: 3.575

5.  Decreased antioxidant status in migraine patients with brain white matter hyperintensities.

Authors:  Bilal Aytaç; Özlem Coşkun; Bülent Alioğlu; Zahide Esra Durak; Süleyman Büber; Esra Tapçi; Ruhşen Ocal; Levent Ertuğrul Inan; İlker Durak; Tahir Kurtuluş Yoldaş
Journal:  Neurol Sci       Date:  2014-07-10       Impact factor: 3.307

6.  Kynurenines and other novel therapeutic strategies in the treatment of dementia.

Authors:  Zsófia Majláth; János Tajti; László Vécsei
Journal:  Ther Adv Neurol Disord       Date:  2013-11       Impact factor: 6.570

Review 7.  Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety.

Authors:  Délia Szok; Anett Csáti; László Vécsei; János Tajti
Journal:  Toxins (Basel)       Date:  2015-07-17       Impact factor: 4.546

8.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

9.  Gene expression microarray analysis of the spinal trigeminal nucleus in a rat model of migraine with aura.

Authors:  Ruozhuo Liu; Shengyuan Yu; Fengpeng Li; Enchao Qiu
Journal:  Neural Regen Res       Date:  2012-09-05       Impact factor: 5.135

10.  American football and other sports injuries may cause migraine/persistent pain decades later and can be treated successfully with electrical twitch-obtaining intramuscular stimulation (ETOIMS).

Authors:  J Chu; S McNally; F Bruyninckx; D Neuhauser
Journal:  BMJ Innov       Date:  2017-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.